※ 출처: ClinicalTrials.gov
총 556건

해외임상승인현황 정보 :: 순번, 임상시험 제목, 적응증, 연구설계, 의뢰자/실시기관, 임상단계, 게시일자
순번 임상시험 제목 적응증 연구설계 의뢰자/실시기관 임상단계 게시일자
1 β-globin Restored Autologous HSC in β-thalassemia Major Patients β-thalassemia Major Biological: β-globin restored autologous HSC Shanghai Bioray Laboratory Inc.|PLA 923 Hospital Phase 1|Phase 2 2020-07-01
2 Phase I Clinical Trial of a Candidate PCV13 in Healthy People Aged 6 Weeks and Above Pneumococcal Infections|Streptococcal Infections|Bacterial Infections Biological: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine(CRM197,TT)|Biological: 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine CanSino Biologics Inc.|Henan Center for Disease Control and Prevention Phase 1 2020-05-18
3 Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . Diphtheria|Tetanus|Pertussis Biological: Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed|Biological: Diphtheria and Tetanus Combined Vaccine, Adsorbed|Biological: Diphtheria-tetanus-acellular pertussis vaccine|Biological: Diphtheria,tetanus,pertussis(acellular,component),poliomyelitis(inactivated) vaccine(absorbed) and Haemophilus influenzae type b conjugate vaccine CanSino Biologics Inc.|Henan Center for Disease Control and Prevention Phase 1 2020-04-28
4 Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer Advanced Breast Cancer Biological: Activated CIK and CD3-MUC1 Bispecific Antibody in Treating Breast Cancer|Procedure: cryotherapy Fuda Cancer Hospital, Guangzhou|Benhealth Biopharmaceutical (Shenzhen) Co., Ltd. Phase 2 2020-04-05
5 A Phase I PK Similarity Study of Sintilimab by Different Production Process in Advanced or Metastatic NSCLC Patients Advanced or Metastatic NSCLC Drug: Sintilimab (M1b)|Drug: Sintilimab (approved) Innovent Biologics (Suzhou) Co. Ltd. Phase 1 2020-04-02
6 Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) Esophageal Squamous Cell Carcinoma (ESCC)|Siewert Type I Adenocarcinoma of the Esophagogastric Junction (EGJ)|Esophageal Adenocarcinoma (EAC) Biological: pembrolizumab|Drug: placebo|Drug: cisplatin|Drug: 5-FU|Radiation: radiotherapy|Drug: leucovorin|Drug: levoleucovorin|Drug: oxaliplatin Merck Sharp & Dohme Corp. Phase 3 2020-02-28
7 Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib ALK-positive Non-small Cell Lung Cancer Drug: Alkotinib Capsules Suzhou Zelgen Biopharmaceuticals Co.,Ltd Phase 2 2020-01-20
8 Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of Age Influenza Biological: Quadrivalent Influenza Vaccine|Biological: Trivalent Influenza Vaccine 1 SP Shz TIV1|Biological: Trivalent Influenza Vaccine 2 SP Shz TIV2 Sanofi Pasteur, a Sanofi Company|Sanofi Phase 3 2020-01-09
9 Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors Advanced Solid Tumors Biological: KN044 Changchun Intellicrown Pharmaceutical Co. LTD Phase 1 2020-01-09
10 A Phase I Study Evaluating SCB-313(Recombinant Human TRAIL-Trimer Fusion Protein) for the Treatment of Malignant Pleural Effusion Malignant Pleural Effusion Drug: SCB-313 Sichuan Clover Biopharmaceuticals, Inc. Phase 1 2020-01-08